Global Positron Emission Tomography (ANIMAL) Market to Reach $2.7 Billion by 2030. In the altered post COVID-19 business landscape, the international market for Positron Emission Tomography (ANIMAL) approximated at US$1.9 Billion in the year 2022, is predicted to reach a modified size of US$2.7 Billion by 2030, growing at aCAGR of 4.8% over the duration 2022-2030.
New York, July 07, 2023 (WORLD NEWSWIRE) — Reportlinker.com reveals the release of the report “Global Positron Emission Tomography (ANIMAL) Industry” –
PET-CT, among the sections examined in the report, is predicted to tape-record 5% CAGR and reach US$2.3 Billion by the end of the analysis duration. Taking into account the continuous post pandemic healing, development in the PET-MRI sector is adjusted to a modified 3.9% CAGR for the next 8-year duration.
The U.S. Market is Estimated at $512.8 Million, While China is Forecast to Grow at 8.1% CAGR
The Positron Emission Tomography (ANIMAL) market in the U.S. is approximated at US$512.8 Million in the year 2022. China, the world`s second biggest economy, is anticipated to reach a predicted market size of US$591.3 Million by the year 2030 tracking a CAGR of 8.1% over the analysis duration 2022 to 2030. Among the other notable geographical markets are Japan and Canada, each projection to grow at 2.5% and 4% respectively over the 2022-2030 duration. Within Europe, Germany is anticipated to grow at roughly 3.2% CAGR.
Select Competitors (Total 42 Featured)
– Advanced Accelerator Applications SA
– Best ABT Molecular Imaging, Inc.
– Curasight A/S
– Digiray Corporation
– DuchemBio, Co., Ltd.
– GE Healthcare
– Hitachi Ltd.
– Neusoft Corporation
– PETsys Electronics SA
– Philips Healthcare
I. METHOD
II. EXECUTIVE SUMMARY
1. MARKET INTRODUCTION
Influencer Market Insights
World Market Trajectories
Positron Emission Tomography (ANIMAL) – Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence – Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. CONCENTRATE ON SELECT GAMERS
3. MARKET TRENDS & DRIVERS
4. WORLDWIDE MARKET POINT OF VIEW
Table 1: World Positron Emission Tomography (ANIMAL) Market
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2030
Table 2: World Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Geographic Region – U.S.A.,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 3: World Historic Review for Positron Emission Tomography
(ANIMAL) by Geographic Region – U.S.A., Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 4: World 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Geographic Region – Percentage Breakdown of
Value Sales for U.S.A., Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2014, 2023 & 2030
Table 5: World Recent Past, Current & Future Analysis for
PET-CT by Geographic Region – U.S.A., Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 6: World Historic Review for PET-CT by Geographic Region –
U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 7: World 16-Year Perspective for PET-CT by Geographic
Region – Percentage Breakdown of Value Sales for U.S.A., Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 8: World Recent Past, Current & Future Analysis for
PET-MRI by Geographic Region – U.S.A., Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 9: World Historic Review for PET-MRI by Geographic Region –
U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 10: World 16-Year Perspective for PET-MRI by Geographic
Region – Percentage Breakdown of Value Sales for U.S.A., Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 11: World Recent Past, Current & Future Analysis for Full
Ring by Geographic Region – U.S.A., Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 12: World Historic Review for Full Ring by Geographic
Region – U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 13: World 16-Year Perspective for Full Ring by Geographic
Region – Percentage Breakdown of Value Sales for U.S.A., Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 14: World Recent Past, Current & Future Analysis for
Partial Ring by Geographic Region – U.S.A., Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 15: World Historic Review for Partial Ring by Geographic
Region – U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 16: World 16-Year Perspective for Partial Ring by
Geographic Region – Percentage Breakdown of Value Sales for
U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 17: World Recent Past, Current & Future Analysis for
Oncology by Geographic Region – U.S.A., Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 18: World Historic Review for Oncology by Geographic
Region – U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 19: World 16-Year Perspective for Oncology by Geographic
Region – Percentage Breakdown of Value Sales for U.S.A., Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for
Cardiology by Geographic Region – U.S.A., Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for Cardiology by Geographic
Region – U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 22: World 16-Year Perspective for Cardiology by
Geographic Region – Percentage Breakdown of Value Sales for
U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 23: World Recent Past, Current & Future Analysis for
Neurology by Geographic Region – U.S.A., Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 24: World Historic Review for Neurology by Geographic
Region – U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 25: World 16-Year Perspective for Neurology by Geographic
Region – Percentage Breakdown of Value Sales for U.S.A., Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region – U.S.A., Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Other Applications by
Geographic Region – U.S.A., Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 28: World 16-Year Perspective for Other Applications by
Geographic Region – Percentage Breakdown of Value Sales for
U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 29: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region – U.S.A., Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 30: World Historic Review for Hospitals by Geographic
Region – U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 31: World 16-Year Perspective for Hospitals by Geographic
Region – Percentage Breakdown of Value Sales for U.S.A., Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 32: World Recent Past, Current & Future Analysis for
Diagnostic Centers by Geographic Region – U.S.A., Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 33: World Historic Review for Diagnostic Centers by
Geographic Region – U.S.A., Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 34: World 16-Year Perspective for Diagnostic Centers by
Geographic Region – Percentage Breakdown of Value Sales for
U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 35: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region – U.S.A., Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 36: World Historic Review for Other End-Uses by
Geographic Region – U.S.A., Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 37: World 16-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
U.S.A., Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Positron Emission Tomography (ANIMAL) Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in the United States
for 2023 (E)
Table 38: U.S.A. Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Modality – PET-CT and
PET-MRI – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 39: U.S.A. Historic Review for Positron Emission Tomography
(ANIMAL) by Modality – PET-CT and PET-MRI Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 40: U.S.A. 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Modality – Percentage Breakdown of Value
Sales for PET-CT and PET-MRI for the Years 2014, 2023 & 2030
Table 41: U.S.A. Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Type – Full Ring and
Partial Ring – Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 42: U.S.A. Historic Review for Positron Emission Tomography
(ANIMAL) by Type – Full Ring and Partial Ring Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 43: U.S.A. 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Type – Percentage Breakdown of Value Sales
for Full Ring and Partial Ring for the Years 2014, 2023 & 2030
Table 44: U.S.A. Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Application – Oncology,
Cardiology, Neurology and Other Applications – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 45: U.S.A. Historic Review for Positron Emission Tomography
(ANIMAL) by Application – Oncology, Cardiology, Neurology and
Other Applications Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 46: U.S.A. 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Application – Percentage Breakdown of Value
Sales for Oncology, Cardiology, Neurology and Other
Applications for the Years 2014, 2023 & 2030
Table 47: U.S.A. Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by End-Use – Hospitals,
Diagnostic Centers and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 48: U.S.A. Historic Review for Positron Emission Tomography
(ANIMAL) by End-Use – Hospitals, Diagnostic Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR
Table 49: U.S.A. 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by End-Use – Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Centers and Other End-Uses for
the Years 2014, 2023 & 2030
CANADA
Table 50: Canada Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Modality – ANIMAL-CT and
ANIMAL-MRI – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 51: Canada Historic Review for Positron Emission
Tomography (ANIMAL) by Modality – ANIMAL-CT and ANIMAL-MRI Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 52: Canada 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Modality – Percentage Breakdown of Value
Sales for ANIMAL-CT and ANIMAL-MRI for the Years 2014, 2023 & 2030
Table 53: Canada Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Type – Full Ring and
Partial Ring – Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 54: Canada Historic Review for Positron Emission
Tomography (ANIMAL) by Type – Full Ring and Partial Ring Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 55: Canada 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Type – Percentage Breakdown of Value Sales
for Full Ring and Partial Ring for the Years 2014, 2023 & 2030
Table 56: Canada Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Application – Oncology,
Cardiology, Neurology and Other Applications – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 57: Canada Historic Review for Positron Emission
Tomography (ANIMAL) by Application – Oncology, Cardiology,
Neurology and Other Applications Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 58: Canada 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Application – Percentage Breakdown of Value
Sales for Oncology, Cardiology, Neurology and Other
Applications for the Years 2014, 2023 & 2030
Table 59: Canada Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by End-Use – Hospitals,
Diagnostic Centers and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 60: Canada Historic Review for Positron Emission
Tomography (ANIMAL) by End-Use – Hospitals, Diagnostic Centers and
Other End-Uses Markets – Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 61: Canada 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by End-Use – Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Centers and Other End-Uses for
the Years 2014, 2023 & 2030
JAPAN
Positron Emission Tomography (ANIMAL) Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in Japan for 2023 (E)
Table 62: Japan Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Modality – ANIMAL-CT and
ANIMAL-MRI – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 63: Japan Historic Review for Positron Emission
Tomography (ANIMAL) by Modality – ANIMAL-CT and ANIMAL-MRI Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 64: Japan 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Modality – Percentage Breakdown of Value
Sales for ANIMAL-CT and ANIMAL-MRI for the Years 2014, 2023 & 2030
Table 65: Japan Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Type – Full Ring and
Partial Ring – Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 66: Japan Historic Review for Positron Emission
Tomography (ANIMAL) by Type – Full Ring and Partial Ring Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 67: Japan 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Type – Percentage Breakdown of Value Sales
for Full Ring and Partial Ring for the Years 2014, 2023 & 2030
Table 68: Japan Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Application – Oncology,
Cardiology, Neurology and Other Applications – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 69: Japan Historic Review for Positron Emission
Tomography (ANIMAL) by Application – Oncology, Cardiology,
Neurology and Other Applications Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 70: Japan 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Application – Percentage Breakdown of Value
Sales for Oncology, Cardiology, Neurology and Other
Applications for the Years 2014, 2023 & 2030
Table 71: Japan Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by End-Use – Hospitals,
Diagnostic Centers and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 72: Japan Historic Review for Positron Emission
Tomography (ANIMAL) by End-Use – Hospitals, Diagnostic Centers and
Other End-Uses Markets – Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 73: Japan 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by End-Use – Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Centers and Other End-Uses for
the Years 2014, 2023 & 2030
CHINA
Positron Emission Tomography (ANIMAL) Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in China for 2023 (E)
Table 74: China Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Modality – ANIMAL-CT and
ANIMAL-MRI – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 75: China Historic Review for Positron Emission
Tomography (ANIMAL) by Modality – ANIMAL-CT and ANIMAL-MRI Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 76: China 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Modality – Percentage Breakdown of Value
Sales for ANIMAL-CT and ANIMAL-MRI for the Years 2014, 2023 & 2030
Table 77: China Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Type – Full Ring and
Partial Ring – Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 78: China Historic Review for Positron Emission
Tomography (ANIMAL) by Type – Full Ring and Partial Ring Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 79: China 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Type – Percentage Breakdown of Value Sales
for Full Ring and Partial Ring for the Years 2014, 2023 & 2030
Table 80: China Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Application – Oncology,
Cardiology, Neurology and Other Applications – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 81: China Historic Review for Positron Emission
Tomography (ANIMAL) by Application – Oncology, Cardiology,
Neurology and Other Applications Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 82: China 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Application – Percentage Breakdown of Value
Sales for Oncology, Cardiology, Neurology and Other
Applications for the Years 2014, 2023 & 2030
Table 83: China Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by End-Use – Hospitals,
Diagnostic Centers and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 84: China Historic Review for Positron Emission
Tomography (ANIMAL) by End-Use – Hospitals, Diagnostic Centers and
Other End-Uses Markets – Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 85: China 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by End-Use – Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Centers and Other End-Uses for
the Years 2014, 2023 & 2030
EUROPE
Positron Emission Tomography (ANIMAL) Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in Europe for 2023 (E)
Table 86: Europe Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Geographic Region –
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 87: Europe Historic Review for Positron Emission
Tomography (ANIMAL) by Geographic Region – France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 88: Europe 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Geographic Region – Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2014, 2023 & 2030
Table 89: Europe Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Modality – ANIMAL-CT and
ANIMAL-MRI – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 90: Europe Historic Review for Positron Emission
Tomography (ANIMAL) by Modality – ANIMAL-CT and ANIMAL-MRI Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 91: Europe 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Modality – Percentage Breakdown of Value
Sales for ANIMAL-CT and ANIMAL-MRI for the Years 2014, 2023 & 2030
Table 92: Europe Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Type – Full Ring and
Partial Ring – Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 93: Europe Historic Review for Positron Emission
Tomography (ANIMAL) by Type – Full Ring and Partial Ring Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 94: Europe 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Type – Percentage Breakdown of Value Sales
for Full Ring and Partial Ring for the Years 2014, 2023 & 2030
Table 95: Europe Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Application – Oncology,
Cardiology, Neurology and Other Applications – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 96: Europe Historic Review for Positron Emission
Tomography (ANIMAL) by Application – Oncology, Cardiology,
Neurology and Other Applications Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 97: Europe 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Application – Percentage Breakdown of Value
Sales for Oncology, Cardiology, Neurology and Other
Applications for the Years 2014, 2023 & 2030
Table 98: Europe Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by End-Use – Hospitals,
Diagnostic Centers and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 99: Europe Historic Review for Positron Emission
Tomography (ANIMAL) by End-Use – Hospitals, Diagnostic Centers and
Other End-Uses Markets – Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 100: Europe 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by End-Use – Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Centers and Other End-Uses for
the Years 2014, 2023 & 2030
FRANCE
Positron Emission Tomography (ANIMAL) Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in France for 2023 (E)
Table 101: France Recent Past, Current & Future Analysis for
Positron Emission Tomography (ANIMAL) by Modality – ANIMAL-CT and
ANIMAL-MRI – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 102: France Historic Review for Positron Emission
Tomography (ANIMAL) by Modality – ANIMAL-CT and ANIMAL-MRI Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 103: France 16-Year Perspective for Positron Emission
Tomography (ANIMAL) by Modality – Percentage Breakdown of Value
Sales for PET-CT and PET-MRI for the Years 2014, 2023 & 2030
Table 104: France Recent Past, Current & Future Analysis for
Positron Emission Tomography (PET) by Type – Full Ring and
Partial Ring – Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 105: France Historic Review for Positron Emission
Tomography (PET) by Type – Full Ring and Partial Ring Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 106: France 16-Year Perspective for Positron Emission
Tomography (PET) by Type – Percentage Breakdown of Value Sales
for Full Ring and Partial Ring for the Years 2014, 2023 & 2030
Table 107: France Recent Past, Current & Future Analysis for
Positron Emission Tomography (PET) by Application – Oncology,
Cardiology, Neurology and Other Applications – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 108: France Historic Review for Positron Emission
Tomography (PET) by Application – Oncology, Cardiology,
Neurology and Other Applications Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 109: France 16-Year Perspective for Positron Emission
Tomography (PET) by Application – Percentage Breakdown of Value
Sales for Oncology, Cardiology, Neurology and Other
Applications for the Years 2014, 2023 & 2030
Table 110: France Recent Past, Current & Future Analysis for
Positron Emission Tomography (PET) by End-Use – Hospitals,
Diagnostic Centers and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 111: France Historic Review for Positron Emission
Tomography (PET) by End-Use – Hospitals, Diagnostic Centers and
Other End-Uses Markets – Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 112: France 16-Year Perspective for Positron Emission
Tomography (PET) by End-Use – Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Centers and Other End-Uses for
the Years 2014, 2023 & 2030
GERMANY
Positron Emission Tomography (PET) Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in Germany for 2023 (E)
Table 113: Germany Recent Past, Current & Future Analysis for
Positron Emission Tomography (PET) by Modality – PET-CT and
PET-MRI – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 114: Germany Historic Review for Positron Emission
Tomography (PET) by Modality – PET-CT and PET-MRI Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 115: Germany 16-Year Perspective for Positron Emission
Tomography (PET) by Modality – Percentage Breakdown of Value
Sales for PET-CT and PET-MRI for the Years 2014, 2023 & 2030
Table 116: Germany Recent Past, Current & Future Analysis for
Positron Emission Tomography (PET) by Type – Full Ring and
Partial Ring – Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 117: Germany Historic Review for Positron Emission
Tomography (PET) by Type – Full Ring and Partial Ring Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 118: Germany 16-Year Perspective for Positron Emission
Tomography (PET) by Type – Percentage Breakdown of Value Sales
for Full Ring and Partial Ring for the Years 2014, 2023 & 2030
Table 119: Germany Recent Past, Current & Future Analysis for
Positron Emission Tomography (PET) by Application – Oncology,
Cardiology, Neurology and Other Applications – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 120: Germany Historic Review for Positron Emission
Tomography (PET) by Application – Oncology, Cardiology,
Neurology and Other Applications Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 121: Germany 16-Year Perspective for Positron Emission
Tomography (PET) by Application – Percentage Breakdown of Value
Sales for Oncology, Cardiology, Neurology and Other
Applications for the Years 2014, 2023 & 2030
Table 122: Germany Recent Past, Current & Future Analysis for
Positron Emission Tomography (PET) by End-Use – Hospitals,
Diagnostic Centers and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 123: Germany Historic Review for Positron Emission
Tomography (PET) by End-Use – Hospitals, Diagnostic Centers and
Other End-Uses Markets – Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 124: Germany 16-Year Perspective for Positron Emission
Tomography (PET) by End-Use – Percentage Breakdown of Value
Sales for Hospitals, Diagnostic Centers and Other End-Uses for
the Years 2014, 2023 & 2030
ITALY
Table 125: Italy Recent Past, Current & Future Analysis for
Positron Emission Tomography (PET) by Modality – PET-CT and
PET-MRI – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 126: Italy Historic Review for Positron Emission
Tomography (PET) by Modality – PET-CT and PET-MRI Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 127: Italy 16-Year Perspective for Positron Emission
Tomography (PET) by Modality – Percentage Breakdown of Value
Sales for PET-CT and PET-MRI for the Years 2014, 2023 & 2030
Table 128: Italy Recent Past, Current & Future Analysis for
Positron Emission Tomography (PET) by Type – Full Ring and
Partial Ring – Independent Analysis of Annual Sales in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 129: Italy Historic Review for Positron Emission
Tomography (PET) by Type – Full Ring and Partial Ring Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 130: Italy 16-Year Perspective for Positron Emission
Tomography (PET) by Type – Percentage Breakdown of Value Sales
for Full Ring and Partial Ring for the Years 2014, 2023 & 2030
Please contact our Customer Support Center to get the total Table of Contents
Read the complete report:
About Reportlinker
ReportLinker is an acclaimed marketing research option. Reportlinker discovers and arranges the latest market information so you get all the marketplace research study you require – quickly, in one location.
__________________________
CONTACT: Clare: [email protected] United States: (339)-368-6001 Intl: +1 339-368-6001
